At the time of writing, Harmony Biosciences Holdings Inc [HRMY] stock is trading at $30.11, down -0.46%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The HRMY shares have gain 15.72% over the last week, with a monthly amount glided 9.45%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Harmony Biosciences Holdings Inc [NASDAQ: HRMY] stock has seen the most recent analyst activity on July 21, 2025, when Truist initiated its Buy rating and assigned the stock a price target of $48. Deutsche Bank started tracking the stock assigning a Buy rating and suggested a price target of $55 on February 11, 2025. H.C. Wainwright initiated its recommendation with a Buy and recommended $75 as its price target on December 17, 2024. In a note dated September 10, 2024, UBS initiated an Buy rating and provided a target price of $56 on this stock.
For the past year, the stock price of Harmony Biosciences Holdings Inc fluctuated between $25.52 and $41.61. Currently, Wall Street analysts expect the stock to reach $43.67 within the next 12 months. Harmony Biosciences Holdings Inc [NASDAQ: HRMY] shares were valued at $30.11 at the most recent close of the market. An investor can expect a potential return of 45.03% based on the average HRMY price forecast.
Analyzing the HRMY fundamentals
According to Harmony Biosciences Holdings Inc [NASDAQ:HRMY], the company’s sales were 772.53M for trailing twelve months, which represents an 16.01% jump. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.29%, and Net Profit Margin reading is 0.23%. To continue investigating profitability, this company’s Return on Assets is posted at 0.16, Equity is 0.26 and Total Capital is 0.24. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 29.57 points at the first support level, and at 29.02 for the second support level. However, for the 1st resistance point, the stock is sitting at 30.81, and for the 2nd resistance point, it is at 31.50.
Ratios To Look Out For
It is important to note that Harmony Biosciences Holdings Inc [NASDAQ:HRMY] has a current ratio of 3.84. Also, the Quick Ratio is 3.80, while the Cash Ratio stands at 3.03. Considering the valuation of this stock, the price to sales ratio is 2.24, the price to book ratio is 2.24 and price to earnings (TTM) ratio is 9.71.
Transactions by insiders
Recent insider trading involved Kapadia Sandip, CHIEF FINANCIAL OFFICER, that happened on Aug 15 ’25 when 21573.0 shares were sold. Officer, SANDIP KAPADIA completed a deal on Aug 15 ’25 to buy 21573.0 shares. Meanwhile, Former Officer JEFFREY G DIERKS bought 5615.0 shares on Jun 10 ’25.
